Global director of ICAP, Wafaa El- Sadr, MD, MPH, MPA, was featured on ABC News on Jan 12 in which she commented on the need for everyone to receive both doses of the COVID-19 vaccine:
“It’s really important to keep stressing that people need the two doses to be able to get the protective level of the 94% efficacy that we talk about. It protects against the impact of the infection, meaning development of disease or severe disease. We don’t know if it protects against infection.”
Read the full article on ABC News.
Read the latest ICAP updates on COVID-19 here
A major global health organization that has been improving public health in countries around the world for over 15 years, ICAP works to transform the health of populations through innovation, science, and global collaboration. Based at Columbia University in New York City, where it is part of the Mailman School of Public Health, ICAP has projects in more than 30 countries, working side-by-side with ministries of health and local partners to confront some of the world’s toughest health challenges. Through meaningful research, tailored technical assistance, effective training and education programs, and rigorous surveillance to measure and evaluate the impact of public health interventions, ICAP aims to realize a global vision of healthy people, empowered communities, and thriving societies. Online at icap.columbia.edu
